These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25393531)

  • 21. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T; Gustafsson B; Brunk UT
    FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).
    Bureš J; Jansová H; Stariat J; Filipský T; Mladěnka P; Šimůnek T; Kučera R; Klimeš J; Wang Q; Franz KJ; Kovaříková P
    J Pharm Biomed Anal; 2015 Feb; 105():55-63. PubMed ID: 25527982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Nov; 50(24):6212-25. PubMed ID: 17963372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P; Mackova E; Haskova P; Vavrova A; Jirkovsky E; Sterba M; Popelova O; Kalinowski DS; Kovarikova P; Vavrova K; Richardson DR; Simunek T
    Chem Res Toxicol; 2010 Jun; 23(6):1105-14. PubMed ID: 20521781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
    Kovaríková P; Mrkvicková Z; Klimes J
    J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues.
    Bernhardt PV; Caldwell LM; Chaston TB; Chin P; Richardson DR
    J Biol Inorg Chem; 2003 Nov; 8(8):866-80. PubMed ID: 14564555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
    Potuckova E; Jansova H; Machacek M; Vavrova A; Haskova P; Tichotova L; Richardson V; Kalinowski DS; Richardson DR; Simunek T
    PLoS One; 2014; 9(2):e88754. PubMed ID: 24586383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells.
    Ji Y; Dai F; Zhou B
    Free Radic Biol Med; 2018 Dec; 129():215-226. PubMed ID: 30240704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells.
    Lovejoy DB; Richardson DR
    Blood; 2002 Jul; 100(2):666-76. PubMed ID: 12091363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
    Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
    Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy.
    Bernhardt PV; Chin P; Richardson DR
    J Biol Inorg Chem; 2001 Oct; 6(8):801-9. PubMed ID: 11713687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands.
    Bernhardt PV; Wilson GJ; Sharpe PC; Kalinowski DS; Richardson DR
    J Biol Inorg Chem; 2008 Jan; 13(1):107-19. PubMed ID: 17899222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture.
    Baker E; Richardson D; Gross S; Ponka P
    Hepatology; 1992 Mar; 15(3):492-501. PubMed ID: 1544632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators.
    Lovejoy DB; Richardson DR
    Curr Med Chem; 2003 Jun; 10(12):1035-49. PubMed ID: 12678675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel iron chelator that does not induce HIF-1 activity.
    Creighton-Gutteridge M; Tyrrell RM
    Free Radic Biol Med; 2002 Aug; 33(3):356-63. PubMed ID: 12126757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide.
    Charkoudian LK; Dentchev T; Lukinova N; Wolkow N; Dunaief JL; Franz KJ
    J Inorg Biochem; 2008 Dec; 102(12):2130-5. PubMed ID: 18835041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of potential toxic effects after repeated 10-week administration of a new iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits.
    Klimtová I; Simůnek T; Mazurová Y; Kaplanová J; Sterba M; Hrdina R; Gersl V; Adamcová M; Ponka P
    Acta Medica (Hradec Kralove); 2003; 46(4):163-70. PubMed ID: 14965167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.